| 72485-0106-10 | LevetiracetamArmas Pharmaceuticals Inc. | 5 × 10 | 50 | 500 | ASP | Q1 2024 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 72485-0106-25 | LevetiracetamArmas Pharmaceuticals Inc. | 5 × 25 | 50 | 1,250 | ASP | Q4 2023 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 70860-0602-82 | LevetiracetamAthenex Pharmaceutical Division, LLC | 100 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | Excluded listingLevetiracetam |
|---|
| 70860-0603-82 | LevetiracetamAthenex Pharmaceutical Division, LLC | 100 × 10 | 100 | 1,000 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | Excluded listingLevetiracetam |
|---|
| 70860-0604-82 | LevetiracetamAthenex Pharmaceutical Division, LLC | 100 × 10 | 150 | 1,500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | Excluded listingLevetiracetam |
|---|
| 00264-1009-90 | LevetiracetamB. Braun Medical Inc. | 100 × 24 | 100 | 2,400 | ASP | Q4 2024 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 00264-1509-90 | LevetiracetamB. Braun Medical Inc. | 100 × 24 | 150 | 3,600 | ASP | Q4 2024 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 00264-5009-90 | LevetiracetamB. Braun Medical Inc. | 100 × 24 | 50 | 1,200 | ASP | Q4 2024 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 36000-0352-40 | LevetiracetamBaxter Healthcare Corporation | 100 × 24 | 50 | 1,200 | ASP | Q2 2025 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 36000-0354-40 | LevetiracetamBaxter Healthcare Corporation | 100 × 24 | 150 | 3,600 | ASP | Q2 2025 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 36000-0356-40 | LevetiracetamBaxter Healthcare Corporation | 100 × 24 | 100 | 2,400 | ASP | Q2 2025 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 65145-0173-10 | LevetiracetamCaplin Steriles USA Inc. | 100 × 10 | 50 | 500 | ASP | Q1 2026 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 65145-0174-10 | LevetiracetamCaplin Steriles USA Inc. | 100 × 10 | 100 | 1,000 | ASP | Q1 2026 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 65145-0175-10 | LevetiracetamCaplin Steriles USA Inc. | 100 × 10 | 150 | 1,500 | ASP | Q1 2026 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 72572-0360-25 | LevetiracetamCivica, Inc. | 5 × 25 | 50 | 1,250 | ASP | Q3 2023 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 43598-0635-10 | LevetiracetamDr. Reddy's Laboratories Inc. | 100 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 43598-0636-10 | LevetiracetamDr. Reddy's Laboratories Inc. | 100 × 10 | 100 | 1,000 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 43598-0637-10 | LevetiracetamDr. Reddy's Laboratories Inc. | 100 × 10 | 150 | 1,500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 43598-0755-10 | LevetiracetamDr. Reddy's Laboratories Inc. | 100 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 43598-0757-10 | LevetiracetamDr. Reddy's Laboratories Inc. | 100 × 10 | 100 | 1,000 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 43598-0759-10 | LevetiracetamDr. Reddy's Laboratories Inc. | 100 × 10 | 150 | 1,500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 55150-0177-05 | LevetiracetamEugia US LLC | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 55150-0246-47 | LevetiracetamEugia US LLC | 100 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 55150-0247-47 | LevetiracetamEugia US LLC | 100 × 10 | 100 | 1,000 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 55150-0248-47 | LevetiracetamEugia US LLC | 100 × 10 | 150 | 1,500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 63323-0400-05 | LevetiracetamFreseniUS Kabi USA, LLC | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 63323-0400-44 | LevetiracetamFreseniUS Kabi USA, LLC | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 65219-0042-71 | LevetiracetamFreseniUS Kabi USA, LLC | 100 × 24 | 50 | 1,200 | ASP | Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 65219-0044-71 | LevetiracetamFreseniUS Kabi USA, LLC | 100 × 24 | 100 | 2,400 | ASP | Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 65219-0046-71 | LevetiracetamFreseniUS Kabi USA, LLC | 100 × 24 | 150 | 3,600 | ASP | Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 00143-9281-10 | LevetiracetamHikma Pharmaceuticals USA Inc. | 100 × 10 | 50 | 500 | ASP | Q1 2026 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam in Sodium Chloride |
|---|
| 00143-9282-10 | LevetiracetamHikma Pharmaceuticals USA Inc. | 100 × 10 | 100 | 1,000 | ASP | Q1 2026 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam in Sodium Chloride |
|---|
| 00143-9283-10 | LevetiracetamHikma Pharmaceuticals USA Inc. | 100 × 10 | 150 | 1,500 | ASP | Q1 2026 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam in Sodium Chloride |
|---|
| 00143-9574-25 | LevetiracetamHikma Pharmaceuticals USA Inc. | 5 × 25 | 50 | 1,250 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 00143-9673-25 | LevetiracetamHikma Pharmaceuticals USA Inc. | 5 × 25 | 50 | 1,250 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 00143-9673-10 | LevetiracetamHIKMA PHARMACEUTICALS USA INC. | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2021Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 67457-0255-10 | LevetiracetamMylan Institutional LLC | 100 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 67457-0265-10 | LevetiracetamMylan Institutional LLC | 100 × 10 | 100 | 1,000 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 67457-0266-10 | LevetiracetamMylan Institutional LLC | 100 × 10 | 150 | 1,500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 67457-0790-05 | LevetiracetamMylan Institutional LLC | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 14789-0110-05 | LevetiracetamNexus Pharmaceuticals, LLC | 100 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam in Sodium Chloride |
|---|
| 14789-0220-10 | LevetiracetamNexus Pharmaceuticals, LLC | 100 × 10 | 100 | 1,000 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam in Sodium Chloride |
|---|
| 14789-0330-15 | LevetiracetamNexus Pharmaceuticals, LLC | 100 × 10 | 150 | 1,500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam in Sodium Chloride |
|---|
| 72205-0120-07 | LevetiracetamNovadoz Pharmaceuticals LLC | 5 × 10 | 50 | 500 | ASP | Q3 2024 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 72205-0120-25 | LevetiracetamNovadoz Pharmaceuticals LLC | 5 × 25 | 50 | 1,250 | ASP | Q3 2024 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 00409-1886-02 | LevetiracetamPfizer Inc | 5 × 25 | 50 | 1,250 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 00409-1886-05 | LevetiracetamPfizer Inc | 5 × 25 | 50 | 1,250 | ASP | Q1 2021 – Q1 2025Not in Q4 2026 file | Excluded listingLevetiracetam |
|---|
| 00409-2011-25 | LevetiracetamPfizer Inc | 5 × 25 | 50 | 1,250 | ASP | Q3 2022 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 25021-0780-05 | LevetiracetamSagent Pharmaceuticals | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | Excluded listingLevetiracetam |
|---|
| 25021-0793-82 | LevetiracetamSagent Pharmaceuticals | 100 × 10 | 50 | 500 | ASP | Q3 2025 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 25021-0794-82 | LevetiracetamSagent Pharmaceuticals | 100 × 10 | 100 | 1,000 | ASP | Q3 2025 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 25021-0795-82 | LevetiracetamSagent Pharmaceuticals | 100 × 10 | 150 | 1,500 | ASP | Q4 2025 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 50474-0002-63 | KeppraUCB, Inc. | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q3 2026Not in Q4 2026 file | ListedKeppra |
|---|
| 44567-0500-10 | LevetiracetamWG Critical Care, LLC | 50 × 10 | 25 | 250 | ASP | Q1 2023 – Q3 2026Not in Q4 2026 file | Excluded listingLevetiracetam |
|---|
| 44567-0501-10 | LevetiracetamWG Critical Care, LLC | 100 × 10 | 50 | 500 | ASP | Q4 2022 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 44567-0501-90 | LevetiracetamWG Critical Care, LLC | 100 × 10 | 50 | 500 | ASP | Q1 2024 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 44567-0502-10 | LevetiracetamWG Critical Care, LLC | 100 × 10 | 100 | 1,000 | ASP | Q4 2022 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 44567-0503-10 | LevetiracetamWG Critical Care, LLC | 100 × 10 | 150 | 1,500 | ASP | Q4 2022 – Q3 2026Not in Q4 2026 file | ListedLevetiracetam |
|---|
| 39822-4000-01 | LevetiracetamX-GEN PHARMACEUTICALS INC | 5 × 10 | 50 | 500 | ASP | Q1 2021 – Q4 2024Not in Q4 2026 file | ListedLevetiracetam |
|---|